CLINICAL_TRIALS
trial_result
· 2020-07-27
Clinical Trial Update: Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse [Phase 1, Phase 2]
Summary
Clinical trial update on prazosin to reduce stress-induced craving and relapse in alcohol dependence (Phase 1/Phase 2; completed).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Alcohol Dependence | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-07-27